TITaiga Inooka

Taiga Inooka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Taiga Inooka has a total of 82 co-authors. Here are the top co-authors by number of shared publications:

  • Taro Kominami

    Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    7 shared publications
  • Koji M. Nishiguchi

    Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    6 shared publications
  • Ryo Tomita

    Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    4 shared publications
  • Shinji Ueno

    Department of Ophthalmology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan

    4 shared publications
  • Shinji Ueno

    Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    4 shared publications
  • Yasuki Ito

    Department of Ophthalmology, Fujita Health University School of Medicine, Toyoake, Japan

    4 shared publications

Latest Publications

  • Open Access

    Longitudinal hemifield-specific macular ganglion cell complex thinning and its association with arterial stiffness in eyes without baseline glaucomatous abnormalities

    by Kensuke Kobayashi, Taiga Inooka, Ryo Tomita, Taro Kominami, Tetsuhito Kojima, Shinji Ueno, Yasuki Ito, Koji M. Nishiguchi, Kenya Yuki

  • Open Access

    DELETION INVOLVING EXON 18 OF RPGRIP1 IS a MAJOR CAUSE OF ACHROMATOPSIA

    by Taiga Inooka, Kei Mizobuchi, Takaaki Hayashi, Akiko Suga, Kazushige Tsunoda, Kazuki Kuniyoshi, Hiroyuki Kondo, Junya Ota, Taro Kominami, Kazutoshi Yoshitake, et al.

    Purpose: To evaluate the prevalence of achromatopsia (ACHM) associated with variants of RPGRIP1 , especially c.2710+374_2895+78del ( RPGRIP1 -ex18-DEL), and to confirm that these phenotypes were consistent with ACHM in Japanese patients. Methods: This retrospective observational study involved a review of medical records from 52 patients across 47 Japanese families; all clinically diagnosed with ACHM. Results: Causative variants for ACHM were identified in 39 families through whole-exome sequencing, whole-genome sequencing, or polymerase chain reaction: PDE6C (13 families), RPGRIP1 -ex18-DEL (11 families), CNGA3 (11 families), CNGB3 (2 families), and GNAT2 (2 families). Patients with ACHM associated with RPGRIP1 -ex18-DEL variants did not exhibit significant difference in phenotype, including spherical equivalent refractive error, best-corrected visual acuity (BCVA), fundus appearance, ellipsoid zone grading of optical coherence tomography, and fundus autofluorescence pattern, compared with those with variants in CNGA3 or PDE6C at baseline (all, P > 0.05). For five patients with ACHM with RPGRIP1 -ex18-DEL variants, no change in BCVA or ellipsoid zone grading was noted over a follow-up period of >10 years (all, P > 0.05). Conclusion: Variants in RPGRIP1 -ex18-DEL are unique hotspots with a high prevalence among Japanese patients with ACHM. Clinical findings in these patients are consistent with those in patients with ACHM from other causative genes.


  • Open Access

    Genotype–Phenotype Correlations in RPGRIP1-Associated Retinal Dystrophy in a Nationwide Japanese Cohort

    by Kei Mizobuchi, Taiga Inooka, Takuya Aoki, Hazuki Anzai, Kaoruko Torii, Kazuki Hashimoto, Akiko Suga, Ryo Ando, Miki Hiraoka, Taro Kominami, et al.

  • Open Access

    Association of High-Density Lipoprotein Cholesterol with Macular Structure in Nonglaucomatous Individuals

    by Taiga Inooka, Ryo Tomita, Ayana Suzumura, Shota Fujikawa, Yuki Kimura, Taro Kominami, Tetsuhito Kojima, Shinji Ueno, Yasuki Ito, Koji M. Nishiguchi, et al.


  • Open Access

    Risk Factors for Adult Axial Length Elongation: A 5-Year Population-Based Cohort Study

    by Taiga Inooka, Yuki Kimura, Shota Fujikawa, Sayuri Yasuda, Taro Kominami, Tetsuhito Kojima, Shinji Ueno, Yasuki Ito, Koji M. Nishiguchi, Kenya Yuki


  • Open Access

    Evolving Consultation: Enhancing Ophthalmic Diagnostic Performance Using Large Language Model

    by Taiga Inooka, Hikaru Ota, Yosuke Taki, Sayuri Yasuda, Ai Fujita Sajiki, Ayana Suzumura, Hideyuki Shimizu, Jun Takeuchi, Ryo Tomita, Taro Kominami, et al.


  • GENETIC ETIOLOGY AND CLINICAL FEATURES OF ACHROMATOPSIA IN JAPAN

    by Taiga Inooka, Takaaki Hayashi, Kazushige Tsunoda, Kazuki Kuniyoshi, Hiroyuki Kondo, Kei Mizobuchi, Akiko Suga, Takeshi Iwata, Kazutoshi Yoshitake, Mineo Kondo, et al.

    Purpose: To ascertain the characteristics of achromatopsia (ACHM) in Japan by analyzing the genetic and phenotypic features of patients with ACHM. Methods: The medical records of 52 patients from 47 Japanese families who were clinically diagnosed with ACHM were reviewed in this retrospective observational study. Results: Thirty-six causative variants of ACHM were identified in 26 families via whole-exome sequencing: PDE6C (12 families), CNGA3 (10 families), CNGB3 (two families), and GNAT2 (two families). However, none of the 6 causative variants that are known to cause ACHM, or the 275 other genes listed in RetNet, were observed in 19 families. A significant trend toward older age and worsening of ellipsoid zone disruption on optical coherence tomography images was observed (P < 0.01). Progressive ellipsoid zone disruptions were observed in 13 eyes of seven patients during the follow-up visits. These patients harbored one or more variants in PDE6C. Conclusion: The ACHM phenotype observed in this study was similar to those observed in previous reports; however, the causative gene variants differed from those in Europe. The low identification ratio of causative genes in whole-exome sequencing suggests the presence of unique hotspots in Japanese patients with ACHM that were not detectable via ordinal whole-exome sequencing.


  • Open Access

    Assessment of factors affecting flicker ERGs recorded with RETeval from data obtained from health checkup screening

    by Taiga Inooka, Taro Kominami, Shunsuke Yasuda, Yoshito Koyanagi, Junya Ota, Satoshi Okado, Ryo Tomita, Yasuki Ito, Takeshi Iwase, Hiroko Terasaki, et al.

    Purpose: To determine the factors significantly associated with the amplitudes and implicit times of the flicker electroretinograms (ERGs) recorded with the RETeval system by analyzing the comprehensive data obtained during a health checkup screening. Methods: Flicker ERGs were recorded with the RETeval system from 373 individuals who had a normal fundus and optical coherence tomography images. The sex, age, anthropometric, ophthalmologic, and hematologic data were collected from all participants who were 40- to 89-years-of-age. Univariable and multivariable linear mixed effects regression analyses were performed to identify factors that were significantly associated with the implicit times and amplitudes of the RETeval flicker ERGs. Results: Univariable linear mixed effects regression analysis showed significant correlations between the implicit times and the best-corrected visual acuity, the age, the axial length, the blood sugar level, and the blood urea nitrogen level. Analyses by multivariable linear mixed effects regression identified that the axial length (β = 0.28), the age (β = 0.24), and the blood sugar level (β = 0.092) were three independent factors that were significantly correlated with the implicit times of the RETeval flicker ERGs. Univariable linear mixed effects regression analysis also showed significant correlations between the amplitudes of the RETeval flicker ERGs and the age, the platelet count, and the creatinine level. Multivariable linear mixed effects regression models identified the age (β = -0.092), the platelet count (β = 0.099), and the creatinine level (β = -0.12) as three independent factors that were significantly correlated with the amplitudes of the RETeval flicker ERGs. However, the smoking habits, body mass index, and the blood pressure were not significantly correlated with either the implicit times or amplitudes of the RETeval flicker ERGs. Conclusions: Our results indicate that the age and some ophthalmologic and hematologic findings but not the anthropometric findings were significantly associated with the implicit times and amplitudes of the RETeval flicker ERGs. Thus, clinicians should remember these factors when analyzing the RETeval flicker ERGs.


  • Open Access

    ASSESSMENTS OF MACULAR FUNCTION BY FOCAL MACULAR ELECTRORETINOGRAPHY AND STATIC PERIMETRY IN EYES WITH RETINITIS PIGMENTOSA

    by Satoshi Okado, Yoshito Koyanagi, Taiga Inooka, Taro Kominami, Hiroko Terasaki, Koji M. Nishiguchi, Shinji Ueno

    Purpose: To assess the macular function by focal macular electroretinography and static perimetry in eyes with retinitis pigmentosa. Methods: Eighty-eight eyes of 88 retinitis pigmentosa patients were analyzed. The relationships between the focal macular electroretinography components and the mean deviations (MDs) of the Humphrey Field Analyzer 10-2 were determined. Spectral-domain optical coherence tomography was used to determine the integrity of the ellipsoid zone (EZ) and the interdigitation zone. Results: Forward–backward stepwise regression analyses showed that the amplitudes (r = 0.45, P < 0.01) and implicit times (r = −0.29, P < 0.01) of the b-waves were significantly correlated with the MDs. Some of the eyes had reduced b-wave amplitudes (µV) and disrupted interdigitation zone, despite having a better MD (≥ −10.0 dB) and intact EZ. Subgroup analyses of eyes with better MD (≥ −10.0 dB) showed that the EZ width was correlated with the MDs but not with the b-wave amplitude. The thickness of the EZ–retinal pigment epithelium as an alternative indicator of interdigitation zone was correlated with the b-wave amplitude (r = 0.32, P = 0.04) but not with the MDs (r = −0.10, P = 0.53). Conclusion: The fact that the focal macular electroretinography amplitudes are reduced before the shortening of the EZ in the early stage of retinitis pigmentosa indicates that the focal macular electroretinography amplitudes are an earlier indicator of macular dysfunction than the Humphrey Field Analyzer 10-2 findings.